Physician profile
Bengt Grua
NPI 1275093650
$13,331.63
in general payments reported to CMS, 2019-2025
9 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,704 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,189 · Consulting Fee: $3,200 · Food and Beverage: $2,842 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,188.51 |
| Consulting Fee | $3,200.00 |
| Food and Beverage | $2,842.36 |
| Education | $100.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,557.28 | 2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $4,049.86 | 2024-2025 | Intracept, Superion Indirect Decompression System, Accolade Sr |
| Medtronic, INC. | $1,091.07 | 2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Stryker Corporation | $271.75 | 2025 | Mild Device Kit, Spinejack |
| Spr Therapeutics, INC | $192.82 | 2024-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $82.62 | 2024-2025 | |
| Abbvie INC. | $33.33 | 2024 | |
| Globus Medical, INC. | $32.24 | 2025 | Senza |
| Saluda Medical Americas, INC. | $20.66 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bengt Grua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.